Literature DB >> 17314160

Analysis of hepatitis C virus hypervariable region 1 sequence from cryoglobulinemic patients and associated controls.

Gabriella Bianchettin1, Claudia Bonaccini, Romina Oliva, Anna Tramontano, Agostino Cividini, Milvia Casato, Giampaolo Merlini, Enrico Silini, Mario U Mondelli.   

Abstract

Chronic hepatitis C virus (HCV) infection is frequently associated with extrahepatic manifestations, including nonmalignant and malignant B-cell lymphoproliferative disorders. It has been reported that specific changes or recurring motifs in the amino acid sequence of the HCV hypervariable region 1 (HVR1) may be associated with cryoglobulinemia. We searched for specific insertions/deletions and/or amino acid motifs within HVR1 in samples from 80 symptomatic and asymptomatic patients with and 33 patients without detectable cryoglobulins, all with chronic HCV infection. At variance with the results of a previous study which reported a high frequency of insertions at position 385 of HVR1 from cryoglobulinemic patients, we found a 6.2% prevalence of insertions in samples from patients with and a 9.1% prevalence in those without cryoglobulinemia. Moreover, statistical and bioinformatics approaches including Fisher's exact test, k-means clustering, Tree determinant-residue identification, correlation of mutations, principal component analysis, and phylogenetic analysis failed to show statistically significant differences between sequences from cryoglobulin-negative and -positive patients. Our findings suggest that cryoglobulinemia may arise by virtue of as-yet-unidentified host- rather than virus-specific factors. Specific changes in HCV envelope sequence distribution are unlikely to be directly involved in the establishment of pathological B-cell monoclonal proliferation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17314160      PMCID: PMC1900144          DOI: 10.1128/JVI.02104-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

1.  Automatic methods for predicting functionally important residues.

Authors:  Antonio del Sol; Antonio del Sol Mesa; Florencio Pazos; Alfonso Valencia
Journal:  J Mol Biol       Date:  2003-02-28       Impact factor: 5.469

2.  WebLogo: a sequence logo generator.

Authors:  Gavin E Crooks; Gary Hon; John-Marc Chandonia; Steven E Brenner
Journal:  Genome Res       Date:  2004-06       Impact factor: 9.043

3.  Association of HCV-related mixed cryoglobulinemia with specific mutational pattern of the HCV E2 protein and CD81 expression on peripheral B lymphocytes.

Authors:  Wolf Peter Hofmann; Eva Herrmann; Bernd Kronenberger; Christian Merkwirth; Christoph Welsch; Thomas Lengauer; Stefan Zeuzem; Christoph Sarrazin
Journal:  Blood       Date:  2004-08-15       Impact factor: 22.113

Review 4.  Natural history of hepatitis C.

Authors:  A Alberti; L Chemello; L Benvegnù
Journal:  J Hepatol       Date:  1999       Impact factor: 25.083

5.  A simple method for displaying the hydropathic character of a protein.

Authors:  J Kyte; R F Doolittle
Journal:  J Mol Biol       Date:  1982-05-05       Impact factor: 5.469

6.  A 385 insertion in the hypervariable region 1 of hepatitis C virus E2 envelope protein is found in some patients with mixed cryoglobulinemia type 2.

Authors:  M Gerotto; F Dal Pero; S Loffreda; F B Bianchi; A Alberti; M Lenzi
Journal:  Blood       Date:  2001-11-01       Impact factor: 22.113

7.  Regression of lymphoproliferative disorder after treatment for hepatitis C virus infection in a patient with partial trisomy 3, Bcl-2 overexpression, and type II cryoglobulinemia.

Authors:  Milvia Casato; Cristina Mecucci; Vincent Agnello; Massimo Fiorilli; Glenn B Knight; Caterina Matteucci; Lei Gao; Jonathan Kay
Journal:  Blood       Date:  2002-03-15       Impact factor: 22.113

8.  Histological and virological features and follow-up of hepatitis C virus carriers with normal aminotransferase levels: the Italian prospective study of the asymptomatic C carriers (ISACC).

Authors:  Claudio Puoti; Roberto Castellacci; Fabrizio Montagnese; Serena Zaltron; Gianfranca Stornaiuolo; Nicoletta Bergami; Lia Bellis; Davide F Precone; Paolo Corvisieri; Massimo Puoti; Eliseo Minola; Giovanni Battista Gaeta
Journal:  J Hepatol       Date:  2002-07       Impact factor: 25.083

9.  Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection.

Authors:  Olivier Hermine; François Lefrère; Jean-Pierre Bronowicki; Xavier Mariette; Katayoun Jondeau; Virginie Eclache-Saudreau; Béatrice Delmas; Françoise Valensi; Patrice Cacoub; Christian Brechot; Bruno Varet; Xavier Troussard
Journal:  N Engl J Med       Date:  2002-07-11       Impact factor: 91.245

10.  Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage.

Authors:  F Lunel; L Musset; P Cacoub; L Frangeul; P Cresta; M Perrin; P Grippon; C Hoang; D Valla; J C Piette
Journal:  Gastroenterology       Date:  1994-05       Impact factor: 22.682

View more
  6 in total

1.  Identification of a hepatitis C virus mutant lacking the hypervariable region 1 in a chronically infected patient non-responding to PEG-interferon-alpha/ribavirin therapy.

Authors:  D Kmieciak; P Migdalski; J Juszczyk; P P Jagodziński; W H Trzeciak
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-08-28       Impact factor: 3.267

2.  Association of BAFF -871C/T Promoter Polymorphism with Hepatitis C-Related Mixed Cryoglobulinemia in a Cohort of Egyptian Patients.

Authors:  Mona Wagdy Ayad; Amany A Elbanna; Dalia A Elneily; Amany S Sakr
Journal:  Mol Diagn Ther       Date:  2015-04       Impact factor: 4.074

3.  Efficacy and safety of long-term treatment with low-dose rituximab for relapsing mixed cryoglobulinemia vasculitis.

Authors:  Stefania Colantuono; Milica Mitrevski; Baoran Yang; Julia Tola; Maurizio Carlesimo; Giuseppe M De Sanctis; Massimo Fiorilli; Milvia Casato; Marcella Visentini
Journal:  Clin Rheumatol       Date:  2017-01-22       Impact factor: 2.980

4.  Genome-wide association study of hepatitis C virus- and cryoglobulin-related vasculitis.

Authors:  A L Zignego; G L Wojcik; P Cacoub; M Visentini; M Casato; A Mangia; R Latanich; E D Charles; L Gragnani; B Terrier; V Piazzola; L B Dustin; S I Khakoo; M P Busch; G M Lauer; A Y Kim; L Alric; D L Thomas; P Duggal
Journal:  Genes Immun       Date:  2014-07-17       Impact factor: 2.676

Review 5.  Hepatitis C virus-related mixed cryoglobulinemia: is genetics to blame?

Authors:  Laura Gragnani; Elisa Fognani; Alessia Piluso; Anna Linda Zignego
Journal:  World J Gastroenterol       Date:  2013-12-21       Impact factor: 5.742

6.  Role of microRNA profile modifications in hepatitis C virus-related mixed cryoglobulinemia.

Authors:  Elisa Fognani; Carlo Giannini; Alessia Piluso; Laura Gragnani; Monica Monti; Patrizio Caini; Jessica Ranieri; Teresa Urraro; Elisa Triboli; Giacomo Laffi; Anna Linda Zignego
Journal:  PLoS One       Date:  2013-05-01       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.